Stakeholders Ask CMS For Additional TAVR Indications

 
• By Mark McCarty
  
CMS is considering covering TAVR devices to treat aortic stenosis and pure regurgitation. (New Africa/Shutterstock)

More from Cardiology

More from Medtech Insight